Founder of telehealth startup Done sentenced to six years in prison for Adderall fraud scheme
fiercehealthcare - Ruthia He, the founder and former chief executive officer of telehealth startup Done Global, was sentenced to six years in prison on Tuesday and fined $1 million in connection with an Adderall fraud scheme.
AI Summary: A federal judge sentenced the founder of a telehealth startup to six years in prison following conviction in an Adderall‑prescribing fraud scheme. Regulators and prosecutors say the case exposes how virtual care can be gamed to fuel illegal controlled‑substance distribution, and the verdict signals tougher enforcement is coming for bad actors hiding behind telemedicine’s convenience.
Feds push back HIPAA security rule overhaul to July 2027
fiercehealthcare - The 125-page proposed update prompted fierce pushback from hospitals, health systems and other healthcare stakeholders who warned it would place substantial financial burdens on organizations.
AI Summary: Federal regulators have postponed the overhaul of the HIPAA Security Rule, moving implementation to July 2027 to give covered entities and business associates more time to prepare for tightened cybersecurity and compliance requirements. The delay aims to ease operational pressure while agencies finalize technical details and enforcement timelines—yes, more paperwork, but with slightly more breathing room.
Tampa General sues Eli Lilly over pulled 340B discounts
Ella Jeffries / beckershospitalreview - Tampa General (Fla.) Hospital has sued Eli Lilly and Lilly USA, alleging the drugmaker’s decision to cut off the hospital’s 340B pricing access violates Florida’s Deceptive and Unfair Trade Practices Act. According to the July 2 complaint, filed in the U.…
AI Summary: Tampa General Hospital has filed suit against Eli Lilly after the company suspended discounts tied to the 340B drug-pricing program, alleging the move harmed hospitals that rely on those savings to fund patient care. The litigation highlights ongoing tensions over manufacturer discount policies and financial pressures on safety-net providers.
Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
Susan Jaffe / kffhealthnews - Thousands of people who had a Medicare drug plan with zero-dollar premiums last year got small premium increases this year — and didn’t know it. They were dropped from their coverage for failing to pay amounts as little as $8, and most can’t get it again …
AI Summary: Investigations reveal that many Medicare beneficiaries who believed their drug coverage was free later discovered they had lost benefits, often because of plan changes or confusing enrollment processes. The situation exposed gaps in consumer communication and program oversight, prompting calls for clearer disclosures and stronger safeguards to prevent future coverage surprises.
American Cancer Society Reports Latest Global Cancer Statistics; Cancer Cases Approach 21 Million Worldwide, With Burden Projected to Surge 67% by 2050
cancer - New data reveal stark geographic inequities and call for urgent global action on prevention, early detection, and equitable treatment access
AI Summary: The American Cancer Society published updated global cancer statistics showing cases near 21 million and projecting a steep rise by midcentury, highlighting shifting incidence patterns and growing health system strain. The report calls for intensified prevention, screening and investment in equitable cancer control to blunt the projected surge.
- GLOBOCAN and ACS: New global cancer estimates and projections (6)
- Regional responses: conferences, national programs, and research (4)
- Survival gaps: breast, GI, GU cancers and immunotherapy access (5)
- WHO 2026 Global Cancer Report: Urgent calls for action (5)
- All Other Stories
GLOBOCAN and ACS: New global cancer estimates and projections
Regional responses: conferences, national programs, and research
Survival gaps: breast, GI, GU cancers and immunotherapy access
WHO 2026 Global Cancer Report: Urgent calls for action
All Other Stories
Ascension to Buy Tennessee Health System for Nearly $1B
Katie Adams / medcitynews - Ascension is set to acquire Williamson Health, a county-owned health system in Tennessee, in a deal worth nearly $1 billion. Ascension’s offer beat out bids from HCA Healthcare and Optum. The post Ascension to Buy Tennessee Health System for Nearly $1B ap…
AI Summary: Ascension announced plans to buy Williamson Health, an independent Tennessee health system, in a transaction valued at roughly $700M–$1B. The acquisition further consolidates hospital ownership in the region and will shift local governance and operational control to Ascension as the parties work through regulatory and integration steps.
Healthcare workers in Congo strike amid Ebola outbreak: 6 updates
Mariah Taylor / beckershospitalreview - Front-line healthcare workers at the epicenter of the Ebola outbreak in the Democratic Republic of Congo went on strike over a lack of pay and poor working conditions, Reuters reported July 7. Workers from in and outside hospitals said they have worked wi…
AI Summary: Healthcare workers in the Democratic Republic of Congo have launched strike actions amid a surging Ebola outbreak, with fatalities rising and frontline staff protesting working conditions and safety concerns. The walkouts threaten response capacity, complicating efforts to trace contacts, vaccinate and treat patients as authorities scramble to maintain basic outbreak control measures.
For the First Time, a Cell Built From Scratch Grows and Divides
Yasemin Saplakoglu / quantamagazine - Scientists built a synthetic cell that combines more lifelike properties than ever before — proof of concept that it’s possible to bring nonliving materials to life, or something close to it, in the lab. The post For the First Time, a Cell Built From Scra…
AI Summary: Scientists have for the first time built a synthetic cell from scratch that completes a full life cycle — growing and dividing in the lab. The milestone demonstrates control over core cellular processes, opening doors for bespoke biomanufacturing and disease modelling, while reviving familiar ethical and biosafety questions. Yes, it’s breathtaking — and yes, we should probably be cautious.
Hospital groups, GPO push back on CMS’ 2027 outpatient rule
Ella Jeffries / beckershospitalreview - Four groups are condemning CMS’ proposed 2027 Hospital Outpatient Prospective Payment System and Ambulatory Surgery Center rule, which would cut what Medicare pays hospitals for 340B drugs and expand site-neutral payments into a new category of services. …
AI Summary: Major hospital groups and purchasing GPOs are pushing back on CMS’ proposed 2027 outpatient payment rule, warning that reimbursement changes could disrupt provider margins, patient access and group purchasing dynamics. CMS’ proposal would alter outpatient payment calculations; hospitals argue the revisions threaten financial viability of some outpatient services and request policy rework and deeper stakeholder engagement.
The US is hooked on unregulated peptides. But are they effective, or even safe?
livescience - The world of peptides has exploded in wellness circles, but the benefits of injecting these gray-market molecules rest on little clinical evidence.
AI Summary: Unregulated peptide products have proliferated in the US, raising safety and efficacy concerns as federal regulators convene a contentious panel that includes proponents of these off‑label compounds. The debate highlights a market gap where hype often outpaces evidence — and where regulators must decide whether to tidy up the wild west or watch it fester.
WHO says Hantavirus outbreak linked to ship is over
bbc - The World Health Organization's director general says no further cases have been reported since 25 May.
AI Summary: WHO announced the cruise ship–linked hantavirus outbreak is over after investigations found no ongoing transmission tied to the vessel. Public-health teams closed the incident, lifted emergency measures for passengers and crew, and advised continued targeted surveillance at ports. Travelers can breathe easier — but maybe skip the rodent-themed souvenirs.
American Hospital Association names Steve Walsh as next CEO
fiercehealthcare - Walsh is currently the head of the Massachusetts Hospital Association, and will be taking the national stage at a moment of substantial policy and political challenges for the hospital industry.
AI Summary: Steve Walsh was named the next CEO of the American Hospital Association, replacing outgoing leadership and signaling continuity with a public-sector advocacy background. The appointment centers on navigating hospital policy, membership priorities and advocacy at a time of industry consolidation and regulatory pressure — yes, more meetings and memos ahead.
ACA marketplace enrollment down by 3M as of February, new federal data show
fiercehealthcare - New federal data show that 19.2 million individuals were enrolled in Affordable Care Act marketplace plans as of February, down by nearly 3 million from 2025.
AI Summary: New federal data show ACA marketplace enrollment fell by roughly three million people as of February, signaling continuing declines in the individual market. Officials cite affordability, policy and outreach gaps as contributing factors, leaving consumers with narrower plan choices and potential cost pressure. The drop revives debate over measures to stabilize enrollment and access.
- ACA enrollment drops by about 3 million (5)
- Insurers seek median 14% ACA premium increases in 2027 (6)
- All Other Stories
ACA enrollment drops by about 3 million
Insurers seek median 14% ACA premium increases in 2027
All Other Stories
French deaths soar as extreme heat breaks European records
abcnews - The head of the WHO warns that Europe must do more to protect people.
AI Summary: An intense European heatwave drove record temperatures, a rise in heat‑related deaths and urgent public‑health messaging. Hospitals and public services warned of high-risk exposures, provided heat‑illness guidance and advised behavioral changes — from skipping strenuous exercise to treating heat exhaustion — as cities scrambled to protect vulnerable residents and frantically retrofit cooling advice into everyday life.
Cancer drug shortage renews calls for federal action
medicalxpress - Cancer doctors across the United States are running short of essential generic chemotherapy drugs, and some fear the squeeze could force widespread rationing, The New York Times reported.
AI Summary: Hospitals and oncology clinics are facing critical shortages of key chemotherapy agents, forcing clinicians to consider rationing or alternative regimens. The supply squeeze has reignited demands for federal intervention, supply‑chain fixes, and clearer contingency plans to protect patients who can’t exactly wait for bureaucratic miracles.
A Bridge to Nowhere? Medicare’s GLP-1 Coverage Expansion Requires A More Holistic Approach To Weight Management
Sandeep Palakodeti / medcitynews - For seniors, the change in policy will dramatically expand access to a revolutionary medication. But there are also significant risks.The post A Bridge to Nowhere? Medicare’s GLP-1 Coverage Expansion Requires A More Holistic Approach To Weight Management …
AI Summary: Medicare’s planned GLP‑1 coverage “bridge” has kicked off a scramble: policy analysts warn a narrow drug‑centric approach won’t fix weight management, while major retailers are rolling out programs and partnerships to plug access gaps. Expect patchwork solutions, eager pharmacies, and a chorus asking for a more holistic long‑term plan.
- Clinical risks and long-term effectiveness debate (5)
- Medicare Bridge rollout, eligibility and cost questions (5)
- Online prescribing, oversight and soaring GLP‑1 use (4)
- Retailers, pharmacies and manufacturers rush to plug access gaps (4)
- All Other Stories
Clinical risks and long-term effectiveness debate
Medicare Bridge rollout, eligibility and cost questions
Online prescribing, oversight and soaring GLP‑1 use
Retailers, pharmacies and manufacturers rush to plug access gaps
All Other Stories
First use of precision editing to study human embryo development reveals role of master gene
medicalxpress - Research led by the University of Cambridge Loke Center for Trophoblast Research has shown that a genome-editing technique can be used to alter a single gene in human embryonic cells, enabling the study of very early human development in unparalleled deta…
AI Summary: Scientists used precision genome editing in human embryos to identify a 'master' developmental gene that triggers early human development stages. The finding clarifies key molecular steps, offering insights into congenital disorders and embryology, but also reignites ethical debate over experimental editing — cue the lab‑coat philosophers.
A Ban Won’t Stop Abortion Pill Access, Telehealth Providers Say
Kate Wells / kffhealthnews - As a federal court mulls a case that could result in significant restrictions on a pill used in most abortions, providers say they have alternatives to preserve access even in states with bans in place.
AI Summary: Providers and telehealth advocates warn that banning access won’t stop patients from obtaining abortion pills online. Telemedicine and pharmacy workarounds continue to provide routes for care, underscoring limits of state bans and foreshadowing prolonged legal and practical battles over remote prescribing, cross‑border services, and patient privacy.
Ashok Sebastian Komaranchath: Delighted to Speak at the 5th International Oncology Forum on 20–21 June 2026
oncodaily - Ashok Sebastian Komaranchath, Consultant Medical Oncology and Clinical Lead for Oncology Services at Burjeel Cancer Institute, Oman, shared on LinkedIn: “I was delighted to speak at the 5th International Oncology Forum […]
AI Summary: The FDA (and HHS) launched Operation TrialBlazer, an initiative to accelerate and modernize clinical development by streamlining trial design, data sharing and regulatory pathways. The program aims to reclaim trial competitiveness and reduce time‑to‑market, promising faster patient access — if stakeholders can agree on what “modernize” actually means.
Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
Darius Tahir / kffhealthnews - Medicare is testing the use of artificial intelligence to preapprove several healthcare services. Federal health officials say prior authorization can help reduce fraud and contain costs. But doctors and patients describe the trial as “horrendous” and ful…
AI Summary: Reports show Medicare’s push to deploy AI in administrative and clinical workflows has inadvertently created errors and delays, snaring patients and clinicians in a tangle of misclassifications, coverage denials and technical glitches. The rollout highlights risks of scaling automated decision tools without robust testing, oversight and clear escalation pathways for frontline staff.
- Fixing AI: governance, health systems and nursing oversight (4)
- Medicare AI pilot snarls care with denials and delays (3)
- When AI takes action: autonomous clinical agents create risks (4)